Antares Pharma, Inc. (ATRS)

Deferred Revenue

$3.10M

Quarterly · Period ending: · USD

ATRS logo

ATRS Deferred Revenue

Latest reported$3.10M
ATRS Quarterly Deferred Revenue ($0.00 → $3.10M)
High-resolution chart · PNG

ATRS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.